New approaches to treat bacterial infections are badly needed to address the increasing problem of antibiotic-resistance. This study explores phosphonium-functionalized block copolymer micelles as intrinsically antibacterial polymer assemblies. Phosphonium cations with varying alkyl lengths were conjugated to the terminus of a poly(ethylene oxide)-polycaprolactone block copolymer and the phosphonium-functionalized block copolymers were self-assembled to form micelles in aqueous solution. The size, morphology, and z-potential of the assemblies were studied and their abilities to kill Escherichia coli and Staphylococcus aureus were evaluated. It was found that the minimum bactericidal concentration depended on the phosphonium alkyl chain length and different trends were observed for Gram-negative and Gram-positive bacteria.
Introduction
Polymeric nanocarriers, self-assembled nanoscopic materials with domains of different hydrophilicity, have been extensively investigated due to their abilities to encapsulate biomedically relevant cargo and to provide a chemically tunable platform. [1] [2] [3] [4] Common nanocarrier morphologies are spherical micelles 5 , cylindrical micelles, 6, 7 bilayer structures (e.g.
vesicles) 8 and in some circumstances more complex architectures that can be obtained using unconventional polymers or intermolecular interactions. 9 Amphiphilic block copolymers are often the structural components of polymeric nanocarriers, due to the control they provide over the morphology and the well-established chemistry used to synthesize and functionalize them.
By encapsulating hydrophobic compounds into the hydrophobic domains of nanomaterials, these water-insoluble molecules can be dispersed in aqueous solutions. 4, 10, 11 Block copolymer nanocarriers have been and continue to be investigated for the delivery of a large variety of compounds including small molecule drugs, therapeutic nucleic acids, imaging contrast agents, and antibacterial compounds. 1, 4, 12 An increase in the occurrence of pernicious antibiotic resistant bacteria is currently motivating a search for novel ways of combating bacterial infections. The World Health
Organization warns that in order to avoid a return to the "pre-antibiotic" age, researchers and health professionals need to employ new and varied antibiotic treatments of bacterial infections. 13 The ability to incorporate hydrophobic antibacterial compounds into aqueous dispersible nanocarriers allows for increased availability of the drugs at the site of infection. 14 The use of nanocarriers has allowed researchers to utilize traditional antibacterial compounds with improved efficacy. For example, intracellular bacterial infections are often resistant to antibacterial treatment due to the localization of the bacteria in the eukaryotic cells. Maya and coworkers were able to target intracellular Staphylococcus aureus (S. aureus) by encapsulating tetracycline in chitosan nanoparticles. 15 Li et al. demonstrated the encapsulation of antibacterial agents into polymer vesicles that enzymatically degraded in the presence of target bacteria to deliver the antibacterial cargo. 16 Furthermore, Liu and coworkers have recently demonstrated the ability of triclosan-loaded micelles to penetrate into biofilms and to kill the S. aureus residing in the biofilms with greater efficacy than free triclosan. 17 There are many other examples that demonstrate the increase in desirable properties that can be achieved by loading antibacterial small molecules into nanocarrier systems. 12, 18, 19 This approach may also allow for the use new poorly water-soluble antibacterial compounds in the combat of antibacterial resistance.
Far fewer examples exist of nanocarriers with inherently antibacterial units. This is somewhat surprising given the extensive research that has been performed on incorporating functionality into nanocarrier design. 2, 20 The incorporation of silver nanoparticles [21] [22] [23] and/or polymers such as chitosan 24, 25 or other polyammonium cations, 26-29, have been explored as an approach for imparting antibacterial activity to nanocarriers. Previously unexplored is the use of phosphonium cations to impart antibacterial activity to polymeric nanocarriers. Phosphonium cations, like ammonium cations, are thought to interact with the negatively charged structural biopolymers and phospholipids on the outer surfaces of bacteria cell walls, leading to penetration of the cell wall, ultimately resulting in cell death. [29] [30] [31] Here we explore the synthesis and self-assembly of phosphonium end-capped poly(ethylene oxide)-block-polycaprolactone (PEO-b-PCL) copolymers. To the best of our knowledge, this represents the first example of phosphonium-functionalized block copolymer assemblies in aqueous solution. We also demonstrate the antibacterial properties of the assemblies against S.
aureus and E. coli. Furthermore, it is shown that the antibiotic tetracycline can be incorporated into the micelles, potentially providing orthogonal modes of action, where the traditional antibiotic targets specific pathways in bacteria while the phosphonium cation provides membrane disruption ( Figure 1 ). While work exists demonstrating the benefit of combining antibacterial nanoparticles with traditional antibacterial small molecules 25, 37 the deliberate encapsulation of a traditional antibacterial agent within an intrinsically antibacterial polymeric nanocarrier has not been reported. 
Experimental

General procedures and materials
Methoxy and azide-terminated block copolymers (MeO-BCP and N 3 -BCP respectively) were prepared as previously reported 38 and the characterization data for the specific batches used in the current work are included in the supporting information. Briefly, they were prepared by ringopening polymerizations of freshly distilled ε-caprolactone in dry toluene initiated by PEO monomethyl ether (MeO-PEO) or PEO monoazide (N 3 -PEO). Methanesulfonic acid was used as a catalyst, and the product was obtained by precipitation into cold hexanes. Solvents were dried using an MBraun Solvent Purification System. Dried solvent was collected under vacuum in a flame-dried Straus flask and stored over 4Å molecular sieves. Purified water was obtained using a Barnstead TM EASYPure® II ultra pure water system (ThermoFisher Scientific 
Synthesis of tri-n-octyl(1-pentynyl)phosphonium chloride (Oct 3 P-yne)
Tri-n-octylphosphine (1.00 g, 2.70 mmol, 1.0 equiv.) was dissolved in dry dioxane in a pressure tube inside a glovebox. 5 mg of NaI was added to the reaction mixture. 
Synthesis of Alk 3 P-BCP
(m, C-H).
Self-assembly of block copolymers
Copolymer (5 mg) was dissolved in glass distilled THF (0.5 mL) that had been passed through a 0.22 μm polytetrafluoroethylene filter. The copolymer solution was then added to rapidly stirring purified water (2 mL) that had been passed through an Acrodisc® Syringe Filter (0.45 µm Supor® Membrane) (Pall Life Sciences). The resulting suspension was placed in a 30 °C sand bath overnight to evaporate the THF.
Transmission electron microscopy (TEM)
TEM images were obtained using a Philips CM 10 Transmission Electron Microscope. Selfassembly samples were loaded onto Formvar-coated copper grids by placing the grid on a clean filter paper and dropping 10 µL of a 0.5 -1.0 mg/mL solution onto the grid, and repeating after 30 seconds. The grid was allowed to dry overnight on the filter paper and was imaged the next day. The Alk 3 P-BCP nanocarriers were stained by adding 100 μL of a 1 wt% aqueous auric acid solution to the stock TEM solution and allowing it to stir for one hour to exchange chloride anions with aurate. The sample was then loaded onto the grid as described above.
Determination of the minimum bactericidal concentration (MBC)
The bacteria used were E. coli (ATCC 29425) and S. aureus (ATCC 6538). After inoculation of 10 mL of 0.3 mM pH 7.4 phosphate buffer, the bacteria were cultured overnight in an incubatorshaker at 37 °C. They were then pelletized by centrifugation and the broth was decanted. 10 mL of phosphate solution was then used to resuspend the pellet. The bacteria were again pelletized by centrifugation. This process of resuspension and centrifugation was repeated twice more. For S. aureus, a suspension with an optical density of 0.3 at 600 nm, corresponding to 10 7 CFU/mL was prepared. For E. coli, a suspension with an optical density of 0.2 at 600 nm, corresponding to 10 8 CFU/mL was prepared. These stock solutions were then diluted to ~2 x 10 5 CFU/mL.
Samples for testing were prepared at the highest concentration for testing in 0.3 mM pH 7.4 phosphate buffer and serial two-fold dilutions were performed to achieve lower concentrations. All molecules and assemblies were sterilized by irradiation with UV light in a UV light cabinet for 30 minutes prior to testing. Tests were performed in 96 well plates. Sample wells contained 100 μL of the sample material in phosphate buffer and 100 μL of the bacterial suspension at 10 5 CFU/mL. Control wells contained 100 μL of phosphate buffer and 100 μL of the bacterial suspension at 10 5 CFU/mL. The phosphate buffer was also tested for sterility.
Samples and controls were measured in triplicate. The wells were mixed for 4 hours at ambient temperature using a Tecan infinite M1000 Pro (Tecan Trading AG, Switzerland) plate reader.
The suspensions were then diluted by adding 100 μL of the well contents into 9.9 mL of phosphate buffer to give a resulting bacterial concentration of approximately 10 3 CFU/mL. 100 μL of this suspension was then pour plated in nutrient agar and incubated overnight at 37 °C. The Tables S1 and S2 .
Hemolysis assay
The hemolytic activity of the nanocarriers was determined using sterile defibrinated sheep's blood (Cedarlane Labs, Burlington Ontario, Canada). The blood was pelletized by centrifuging 1 mL of the blood and washing the pellet four times with 0.9 % saline. The pellet was resuspended 
Tetracycline release study
Assemblies containing encapsulated tetracycline were prepared as described above except that 0.3 mM, pH 7.2 phosphate buffer was used. A volume of 2 mL each of tetracycline-loaded
MeO-BCP or Bu 3 P-BCP micelles was then placed on a wrist-action shaker. At measurement time points, centrifugal ultrafiltration was performed as described above to separate released tetracycline from the suspension and the concentrated suspension was diluted again to 2 mL with the phosphate buffer. The absorbance of the filtrate was measured and the concentration of tetracycline in the filtrate was determined based on an e = 14,075 M -1 cm -1 in the same buffer at 363 nm.
Results and Discussion
Synthesis of PEO-b-PCL copolymers
PEO-b-PCL copolymers were selected because of their established biocompatibility and low toxicity in drug delivery applications. 39 An azide terminal group on the PEO was selected for the conjugation of the phosphonium moiety via a copper-assisted azide-alkyne cycloaddition (CuAAC). Methoxy-and azide-terminated PEO-b-PCL copolymers, MeO-BCP and N 3 -BCP respectively, were synthesized according to our previously reported procedure. 38 MeO-PEO or N 3 -PEO were used as macroinitiators to polymerize caprolactone in toluene using methanesulfonic acid (MSA) as a catalyst (Scheme 1). 38 This method yields copolymers with very low molar mass dispersity (Ð). Low Ð is important for good control over the morphology of the self-assemblies. 40 From previous research it is known that a mass ratio of PCL:PEO of 1.3:1 yields micellar nanocarriers. 41 Therefore, using a PEO macroinitiator of ~2000 g/mol, a degree of polymerization (DP) of ~24 caprolactone repeat units was targeted. The resulting block copolymers were characterized by NMR spectroscopy and SEC. 
Synthesis of alkyne-functionalized phosphonium salts
Alkyne-functionalized phosphonium centres were required for conjugation to N 3 -BCP. The lengths of the alkyl chains on phosphonium and ammonium salts are known to affect the antibacterial activity of the small molecules, 32 so it was desirable to explore this in the context of phosphonium-functionalized polymer assemblies. Initial attempts to prepare the alkynefunctionalized phosphonium salts by reaction of trialkylphosphines with propargyl bromide resulted in complex and inseparable product mixtures. This is due to side reactivity of the phosphonium salt with the unreacted phosphine. 42 While addition of hydrobromic acid to the reaction reduced the number of products, isolation of the desired product remained elusive. On the other hand, use of 5-chloro-1-pentyne led to the conversion of triethylphosphine and tri-nbutylphosphine into single products Et 3 P-yne and Bu 3 P-yne, respectively (Scheme 2). The synthesis of Oct 3 P-yne yielded a mixture of products and silica gel column chromatography was used for purification. This was attributed to the extended heating time required to convert the starting material into product as this phosphine is more sterically hindered. In each case, the pure product was characterized by multinuclear magnetic resonance spectroscopy and high resolution mass spectrometry. The products showed characteristic peaks corresponding to both the alkyne and alkyl chains around the phosphonium cation ( Figure 2 ).
Scheme 2.
Synthesis of the phosphonium salts and the phosphonium capped polymers. Due to the onwards use of the polymer in anti-bacterial testing it was imperative that any residual copper be removed from the functionalized materials. The reaction mixtures were therefore dialyzed against large volumes of 0.5 M NaCl solution, followed by water. The dialysis against aqueous NaCl was important to ensure that the phosphonium counterion remained chloride as there are reports in the literature that ascorbate may show antibacterial activity, thus we needed to preclude the chance of anion exchange. 43 As shown in Figure 3 and S9-S10, IR spectra of the initial N 3 -BCP showed strong azide stretches at 2100 cm -1 , whereas this peak was no longer detectable beyond the background noise for the conjugated phosphonium products. Integration of 
Conjugation of the phosphonium cations to the block copolymers
Micelle preparation and characterization
The micelles were prepared from MeO-BCP, Et 3 P-BCP, Bu 3 P-BCP, and Oct 3 P-BCP by nanoprecipitation of a polymer solution in THF into water, which is a selective solvent for the PEO block of the copolymers. The rapid decrease in solubility of the PCL block in the solvent mixture causes the polymers to precipitate into nano-sized cores surrounded by PEO. Figures 4 A-D show representative TEM images of the resulting assemblies. Assemblies prepared from the phosphonium cation-capped polymers were stained using auric acid ( Figure 4B-D) . In this case, the aurate can undergo anion exchange to bind to the positively charged phosphonium ion. 44 In each case, solid spherical particles were observed. The sub-50 nm diameters of the MeO-BCP, Et 3 P-BCP, and Bu 3 P-BCP assemblies suggests that they were largely true micellar structures, whereas some larger 50 -100 nm assemblies were observed for Oct 3 P-BCP, suggesting that some compound micelles or aggregates of micelles were also present. The Oct 3 P-yne is not soluble in water and so installation of this hydrophobic end group on the hydrophilic block may cause this aggregation. As shown in Figure 4E and Table 1 larger Z-average diameter of 59 nm due to the presence of compound micelles or aggregates as noted above. ζ-potentials of the micelles were also measured. MeO-BCP micelles had a ζ-potential of -23 mV. This is typical for assemblies with PEO coronas. 45 On the other hand, all of the phosphonium-functionalized micelles had positive ζ-potentials and these ranged from 19 to 30 mV. This confirms that the phosphonium cations reside on the surface of the micelles.
Interestingly, the value of the ζ-potential increased with the length of the alkyl chain on the phosphonium center. This was somewhat unexpected as the more hydrophobic phosphonium cations could be buried within the PEO corona. However, the results reveal that this may not be the case and the cause of the observed trend in not clear at this time. Oct 3 P-BCP assemblies 58.9 ± 2.8 0.110 ± 0.020 29.7 ± 0.5
Antibacterial properties of phosphonium-functionalized assemblies
The antibacterial efficacies of the phosphonium-functionalized micelles and their corresponding small molecule phosphonium salts were evaluated by measuring their minimum bactericidal concentrations (MBC). The MBC is the concentration required to kill 99% of bacteria in the assay. This assay involved inoculating varying concentrations of the assemblies or small molecules in pH 7.4 phosphate buffer with a bacterial suspension containing 10 5 colony forming units (CFU)/mL of either Gram-negative E. coli (ATCC 29425) or Gram-positive S. aureus (ATCC 6538). The inoculated samples were incubated at 37 °C for 4 hours, then the resulting suspensions were plated on agar, incubated overnight and then the bacterial colonies were counted. The percent reduction, and thus MBC, was calculated by comparing the number of colonies counted after incubation with the sample compared to those of bacteria exposed to only phosphate buffer with no polymer or small molecule added.
As shown in Table 2 , the small molecule phosphonium cations had relatively high MBC values against both E. coli and S. aureus. It was not possible to test Oct 3 P-yne due to its poor aqueous solubility, but Et 3 P-yne had a MBC greater than 45 mM, the highest concentration tested, against S. aureus than E. coli. Bu 3 P-yne was more active, with MBC values of 4.1 mM and 33 mM for S. aureus than E. coli, respectively. MeO-BCP micelles were also studied and the MBC was found to be greater than 1.1 mM in terms of polymer chain concentration for both strains of bacteria, the highest concentration tested. Thus, the block copolymers themselves are not antibacterial. On the other hand, the phosphonium-functionalized assemblies all had much lower MBCs than the small molecules, demonstrating the importance of having a multivalent display of cations. Interestingly there was no observed difference in MBC between the Et 3 P-with E. coli (0.26 mM and 0.13 mM, respectively). The Oct 3 P-BCP assemblies had the greatest activity against S. aureus with an MBC of 0.031 mM, while they had the highest MBC of the phosphonium-functionalized assemblies against E. coli at 0.49 mM. With the exception of Bu 3 P-BCP micelles, higher MBC values were found for E. coli.
The lower efficacy against E. coli was expected based on previous research, and can likely be attributed to differences in the cell wall structures of Gram-positive and Gram-negative bacteria. 46 Gram-positive bacteria such as S. aureus have a plasma membrane surrounded by a periplasmic space and a peptidoglycan layer, whereas Gram-negative bacteria such as E. coli have an additional outer membrane surrounding the peptidoglycan layer. The mode of action of monocationic and polycationic biocides is generally accepted to include the following processes:
1) Biocide adsorption to the cell surface, 2) biocide diffusion through the cell wall, 3) adsorption to the cytoplasmic membrane, 4) cytoplasmic membrane disruption, and 5) loss of cytoplasmic components, resulting in cell death. 31 Gram-negative bacteria have an additional barrier through which the biocide must diffuse, and disrupt, which may explain why higher concentrations of micelles were generally required to kill E. coli.
It was also noted that different trends with respect to alkyl chain length were observed for the different strains of bacteria as Oct 3 P-BCP micelles had the lowest MBC for S. aureus, whereas Bu 3 P-BCP micelles had the lowest MBC for E. coli. While phosphonium groups with longer alkyl chains have been previously demonstrated to show greater antibacterial activity in general 34 there is also data to suggest that the relationship between alkyl chain length and antibacterial efficacy is not linear and in some cases lower activity has been observed with increased alkyl chain length. 47 As hydrophilic cationic groups promote attachment to bacterial membrane and hydrophobic alkyl chains insert into membranes to disrupt them, the hydrophilicity and hydrophobicity must be balanced to match the requirements of the different bacterial membranes. 48 It is also possible that the larger size of the Oct 3 P-BCP assemblies plays a role. The larger size of the individual assemblies results in fewer particles for a given polymer/phosphonium concentration and thus fewer assemblies and less surface area to interact with the bacteria. 49 In comparing the small molecule cationic biocides with polycationic biocides, the small molecules typically have higher rates of diffusion through the cell wall, while the multivalent nature of polycationic biocides increases the adsorption to the cell surface and the cytoplasmic membrane, often leading to increased rates and occurrences of cytoplasmic membrane disruption.
31
The phosphonium-functionalized assemblies can also be compared with other antibacterial polymer assemblies. For example, Du and co-workers demonstrated the preparation of silver nanoparticle-decorated micelles and vesicles with antibacterial activity. 21 These assemblies had a low MBC of 8.69 x 10 -2 mM of Ag. However, it is unclear whether the activity of the system arose from nano-silver associated with the micelles or dissociated Ag + ions released into solution that were not associated with the micellar corona. 21 The mechanism of bacterial killing by nano-silver, while controversial, 50 is also different and is thought to involve the inactivation of the bacterial DNA and ribosomes by silver ions. 51, 52 Later, the same group values for the same material. 27 As the MIC corresponds to the concentration required to inhibit bacterial growth but not necessary kill the bacteria, MIC values are not generally expected to be higher than MBC values. However, this discrepancy may be due to differences in the testing methods. Du and coworkers also reported that low MIC values in the μM range could be achieved against E. coli and S. aureus using polypeptides as the hydrophilic block of a vesicle forming polymeric amphiphile.
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Hemolysis of red blood cells
A challenge often encountered with membrane-active antibacterial agents is that in addition to lysing bacterial cell membranes, they can also lyse the membranes of red blood cells, resulting in non-specific toxicity. Therefore, to evaluate the potential of the phosphonium-functionalized micelles to lyse red blood cells, a hemolysis assay was performed. Briefly, following a previously reported procedure, 54 red blood cells were obtained from defibrinated sheep blood and were incubated with MeO-BCP, Et 3 P-BCP, Bu 3 P-BCP, Oct 3 P-BCP micelles in PBS for 2 hours. As a positive control, red blood cells were suspended in deionized water, resulting in the immediate lysis of the cells. The absorbance of the supernatant at 540 nm after pelletization of the intact blood cells was measured. As shown in Figure 5 , only 0.53 mM of Et 3 P-BCP micelles exhibited any hemolytic activity, with 7% hemolysis observed. Interestingly, this particular system was the least active of the 3 systems against both strains of bacteria, so this result was unexpected. While there is not a complete understanding of all the factors influencing selectivity for eukaryotic and prokaryotic membranes, 46 it is likely that the particular hydrophilichydrophobic balance of the Et 3 P-BCP micelles results in its higher activity against red blood cell membranes. 55 Nevertheless, the overall results suggest that the phosphonium-functionalized micelles have good potential to selectively kill bacteria. While further studies would be required to elucidate the in vitro and in vivo toxicity, previous studies have shown that phosphonium compounds can exhibit low in vitro, 36, 56 and in vivo 56 toxicity. 
Encapsulation and release of tetracycline
The antibacterial efficacy of the phosphonium-functionalized assemblies can potentially be enhanced through encapsulation of a small molecule antibiotic that acts through a mechanism other than membrane disruption, thereby targeting multiple different stages of the infection process. Such an approach has not been explored in the context of antibacterial polymer assemblies to the best of our knowledge. Tetracycline ( Figure 6 ) was chosen as the antibiotic as it is widely used and is hydrophobic, resulting in low aqueous solubility and the possibility to encapsulate it in the hydrophobic PCL cores of the micelles. Tetracycline acts by binding to the bacterial ribosome and preventing the production of new proteins. 57 It was encapsulated in the micelles through co-dissolution with the polymer in CHCl 3 , followed by the addition of water with rapid stirring and heating at 30 °C overnight to evaporate the CHCl 3 . Unencapsulated drug was then removed by centrifugal ultrafiltration ( Figure S14 ). This procedure was performed for both MeO-BCP and Bu 3 P-BCP in order to determine the effect of the phosphonium moieties on the drug loading and release. This afforded assemblies with diameters of 65 ± 5 nm for MeO-BCP as measured by DLS ( Figure S15 ). The amount of drug loaded into the assemblies was determined as the difference between the drug added during assembly and the unencapsulated drug removed by ultrafiltration, which was determined by UV-vis spectroscopy. The EE and DLC were determined to be 31 ± 7 % and 2.0 ± 0.2 % for MeO-BCP and, 42 ± 3 % and 3.1 ± 0.3 % for Bu 3 P-BCP respectively. The higher EE and DLC observed in the Bu 3 P-BCP system may result from ionic interactions between the anionic tetracycline and the cationic phosphonium ions on the micelles. Inset: tetracycline structure
The release rate of tetracycline from the MeO-BCP and Bu 3 P-BCP micelles was then studied by incubating the drug-loaded micelles at 37 °C in pH 7.2 phosphate buffer. At each time point, centrifugal ultrafiltration was used to separate the micelles from the released drug and the concentration of the released drug was measured. As shown in Figure 6 , all of the encapsulated tetracycline was released from the MeO-BCP micelles in ~5 hours. The release of tetracycline was somewhat slower from the Bu 3 P-BCP micelles, with ~70% of the drug being released over the first 5 h and 100% release over 24 h. The differences in release rates between the two systems is likely due to the presence of the phosphonium end cap. Upon release from the hydrophobic micelle core into the phosphate buffer, tetracycline's vinylogous carboxylic acid may become deprotonated and undergo ionic interactions with the phosphonium cations on the surfaces of the micelle, thereby slowing its release.
Antibacterial assays with E. coli were performed to examine the added effect of the tetracycline in the micelle core. It was found that at the tetracycline loadings described above, the activity of the Bu 3 P-BCP micelles was dominated by the phosphonium groups and the same MBC value was determined. No activity was observed for tetracycline-loaded MeO-BCP micelles over a 4 hour incubation at a concentration of 0.26 mM of polymer. This can be attributed to the bacteriostatic effects of tetracycline. On the time scale of the experiment, the tetracycline would not kill bacteria but instead just inhibit its ability to produce new proteins.
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Thus, these experiments were not able to reveal an additive or synergistic effect of the drug and phosphonium on the bacteria. However, this does not preclude the possibility of observing one in vivo where the released drug could exhibit significantly different biodistribution than the assemblies and may reach sites not accessible to the polymer assemblies. Further studies will be needed to investigate this possibility.
Conclusions
In conclusion, this study demonstrated the synthesis and self-assembly of three new phosphonium-functionalized PEO-b-PCL copolymers with varying alkyl chain lengths on the phosphonium. Et 3 P-BCP, Bu 3 P-BCP, and the control MeO-BCP self-assembled into micelles with diameters less than 50 nm, while Oct 3 P-BCP formed larger micelles or aggregates. All of the phosphonium-functionalized assemblies had positive z-potentials, whereas the MeO-BCP micelles had a negative z-potentials. Despite relatively low loadings of the antibacterial component (only a single phosphonium unit per polymer chain), sub-mM MBC values were obtained against both E. coli and S. aureus and the activities of the different systems depended on the bacterial stain due to differences in their cell wall structures. In comparing the MBC values for the assemblies with those of the corresponding phosphonium small molecules, the assemblies were much more effective in killing bacteria, presumably due to their multivalent interactions with the bacteria. The low loadings of the phosphonium groups on the assemblies also allowed then to exhibit excellent hemolytic stability, with only the highest concentration of Et 3 P-BCP micelles showing any hemolytic activity, above the MBC for both S. aureus and E.
coli. It was also demonstrated that the intrinsically antibacterial Bu 3 P-BCP micelles could encapsulate and release tetracycline, providing the potential for an orthogonal mechanism of attack against bacteria during the infection process. Future work will involve further optimization of the system and as well as further exploration of the multifunctional capabilities of these micelles.
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